Clinical trial
Treatment Use of 3,4-Diaminopyridine in Congenital Myasthenic Syndrome
NCT01765140 is registered in ClinicalTrials.gov with Vern C. Juel, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Use of 3,4-Diaminopyridine in Congenital Myasthenic Syndrome
- Lead sponsor
- Vern C. Juel, M.D.
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.